Google
 

Archive for the ‘Blood / Hematology’ Category

Potential For Sensitive Blood Test To Identify Type 1 Diabetes

Tuesday, June 10th, 2008

Knowing who has, or will develop Type-1 diabetes is of immense clinical significance, even as the number of cases of the much more common Type-2 diabetes skyrocket. Because of technology developed at Antigen Express, the wholly-owned subsidiary of NASDAQ-listed oral insulin delivery company Generex Biotechnology, Antigen Express collaborators are now ...

Global Bleeding Disorders Community Gathers In Istanbul

Tuesday, June 10th, 2008

The XXVIII World Congress on hemophilia and related bleeding disorders opened in Istanbul, attracting over 4,200 leading healthcare professionals and delegates from over 115 countries. It is the largest WFH congress in terms of both number of delegates and number of countries represented. New research in diagnosis, management and treatment ...

World Federation Of Hemophilia Closes The Gap In Hemophilia Care

Tuesday, June 10th, 2008

The World Federation of Hemophilia (WFH) has played a key role in bringing about great improvements in the diagnosis and treatment of all people with bleeding disorders, according to data presented by WFH president Mark Skinner at the organization's XXVIII annual meeting in Istanbul, Turkey, this week. "We can demonstrate ...

European Medicines Agency Recommends Measures To Manage Contamination Ofheparin-Containing Medicines

Tuesday, June 10th, 2008

The European Medicines Agency has reviewed the risks associated with the use of heparin medicinal products contaminated with oversulphated chondroitin sulphate (OSCS). Heparins are used to prevent and treat blood clots. They are used widely in patients who could have, or have had a heart attack, in patients who have ...

Research Shows VASER Ultrasound Assisted Lipoplasty Patients Experience Significantly Lower Blood Loss

Saturday, June 7th, 2008

Findings from a comparative analysis study of blood loss during lipoplasty procedures shows VASER ultrasound-assisted lipoplasty causes significantly less blood loss when compared to traditional tumescent lipoplasty. Results of the study were presented at the annual meeting of the American Society for Aesthetic Plastic Surgery held the first week of ...

US Department Of Defense Recommends Soldiers Carry WoundStat™ For Life-Threatening Bleeding

Saturday, June 7th, 2008

TraumaCure Inc. announced that the DOD Joint Committee on Tactical Combat Casualty Care (CoTCCC) has recommended that U.S. soldiers from all services carry the company's hemostatic agent, WoundStat™. The CoTCCC based its recommendations upon the results of extensive studies conducted by both the Army's Institute for Surgical Research (ISR) and ...

ZymoGenetics Announces FDA Approval Of RECOTHROMTM 20,000-IU Vial Size And Co-Packaging With Spray Kit

Monday, June 2nd, 2008

ZymoGenetics, Inc. (NASDAQ:ZGEN) announced that the United States Food and Drug Administration (FDA) has approved a Prior Approval Supplement application for a 20,000 international unit (IU) vial of RECOTHROMTM Thrombin, topical (Recombinant) and also approved co-packaging of the 20,000-IU vial with the ZymoGenetics Spray Applicator Kit. "RECOTHROM, the first and ...

NIMS’ Acceleration Platform Technology Effective In Severe Experimental Hemorrhagic Shock

Monday, June 2nd, 2008

Marvin A Sackner, M.D., Chief Executive Officer and Chairman, Board of Directors, Non-Invasive Monitoring Systems, Inc. [NIMS] (OTCBB:NIMU) announced that Dr. Jose A Adams, Dr. Uryash and their group at Mount Sinai Medical Center of Greater Miami presented two papers at the 9th Scientific Congress of the European Resuscitation Council ...

Sanofi-aventis Withdraws Its Marketing Authorisation Application ForAquilda (satavaptan), Europe

Friday, May 30th, 2008

The European Medicines Agency (EMEA) has been formally notified by Sanofi-Aventis of its decision to withdraw the application for a centralised marketing authorisation for the medicine Aquilda (satavaptan) 5 and 25 mg film-coated tablets. Aquilda was intended to be used for the treatment of euvolaemic and hypervolaemic dilutional hyponatraemia, a ...

No Association Found Between Vitamin D Concentration In Blood And Risk Of Prostate Cancer - May 27 JNCI

Thursday, May 29th, 2008

High vitamin D concentration in the blood is not associated with a reduced risk of prostate cancer, researchers report in an article published online May 27 in the Journal of the National Cancer Institute.Laboratory studies suggested that high doses of vitamin D may reduce the risk of prostate cancer, but ...

For Dialysis Patients, Catheterization Sites Do Not Carry Very Different Infection Risks

Wednesday, May 28th, 2008

According to new research published in the May 28 issue of JAMA,the location of catheter insertion - whether in a vein in a neck or ina vein in the upper leg - does not appear to change the risk ofinfection in critically ill patients who require dialysis. However,heavier patients were ...

Clot Risk From HRT Pills And Patches

Wednesday, May 28th, 2008

"HRT pills DOUBLE the risk of getting blood clots - but patches are safer, say experts," reads the headline in the Daily Mail. It reports on research that has investigated the risk of blood clots from two different forms of hormone replacement therapy (HRT). The newspaper says, "One million ...

AHRQ Announces Guide To Help Patients On Coumadin(R)/Warfarin Therapy

Monday, May 26th, 2008

The U.S. Department of Health and Human Services' (HHS) Agency for Healthcare Research and Quality released a new consumer publication, Your Guide to Coumadin®/Warfarin Therapy. This 20-page, easy-to-read patient brochure explains what patients should expect and watch out for while undergoing Coumadin®/warfarin therapy. ...

Making A Fist Of Blood Taking - And Ending Up In Casualty

Thursday, May 22nd, 2008

A paper in the latest issue of the Annals of Clinical Biochemistry shows how the manner in which blood is collected from patients for some blood tests alters the results of those tests when it comes to analysis. Clenching the fist during blood taking could land some patients in their ...

“Blood Free” Monitoring As Good As Blood Tests In Predicting The Course Of AIDS

Wednesday, May 21st, 2008

Researchers at the University of Pennsylvania School of Medicine have shown that monitoring treatment adherence to AIDS therapy is a simple blood-free way to monitor risk of disease progression. The international study was published in the May issue of the journal PLoS Medicine."The current approach in the developing world, when ...